Skip to content
ANWAL
Saudi Strategic Healthcare Advisory · Riyadh, Saudi Arabia

Strategic counsel for the leaders building healthcare in Saudi Arabia.

ANWAL is a boutique Saudi advisory firm that brings regulation, market access, localization, and investment together under one senior team — so pharmaceutical, medical device, biotechnology, and investment organizations can enter, register, and grow with confidence in one of the world's fastest-moving healthcare markets.

Request a ConsultationExplore Our Practices
4
Advisory practices
6
Sectors served
2030
Aligned with Vision 2030
Who we advise

One advisor for every organization shaping Saudi healthcare

From multinational manufacturers to investors and public-sector entities, we advise the organizations making consequential decisions in the Kingdom's healthcare market — and we tailor our counsel to the realities each of them faces.

Pharmaceutical Companies

Regulatory strategy, market access, localization, and lifecycle decisions across the Saudi market.

Medical Device Companies

Registration pathways, market entry, stakeholder mapping, and commercialization.

Biotechnology Organizations

Market entry, investment readiness, and policy alignment with the Kingdom's biotech ambitions.

Veterinary Healthcare Companies

Product registration, regulatory navigation, and commercial opportunity assessment.

Healthcare Investors

Feasibility, due diligence, partner identification, and entry strategy.

Government & Public-Sector Entities

Transformation support, policy advisory, and private-sector engagement.

What we do

Four practices, one integrated advisor

Most organizations assemble their Saudi strategy from separate vendors — a regulatory consultant, a market-access firm, a lawyer, an investment advisor. ANWAL brings these disciplines together, so decisions in one area strengthen rather than undercut the others.

Regulatory Excellence

End-to-end regulatory strategy, registration, and compliance across pharmaceuticals, devices, and veterinary products.

Market Access & Government Affairs

Structured, ethical stakeholder engagement and policy insight that open durable access pathways.

Localization & Healthcare Investment

Localization strategy, technology transfer, MISA advisory, and investment readiness aligned with Vision 2030.

Executive Healthcare Strategy

Market entry, growth, transformation, and risk advisory for healthcare leadership.

Why ANWAL

Senior judgment, built on the Saudi market

We pair a focused understanding of the Kingdom's healthcare system with the discipline of senior advisory practice — and we keep our engagements small enough to give each one that standard.

  • 01

    Built for the Saudi market

    A focused understanding of the Kingdom's regulators, payers, and policy direction, not a generic playbook applied locally.

  • 02

    Senior attention, by design

    Engagements are led by experienced advisors and framed for boards, CEOs, and country managers — not delegated to junior teams.

  • 03

    Integrated by default

    Regulatory, access, localization, and investment perspectives in one conversation, so trade-offs are seen early.

  • 04

    Built for durability

    Strategies designed for a sustainable market presence, not a short-term entry.

  • 05

    Discreet and principled

    A confidential, hands-on advisory relationship held to a high standard of integrity.

Saudi Healthcare Transformation

Turning national reform into commercial advantage

Saudi Arabia is rebuilding its healthcare system through Vision 2030, the Health Sector Transformation Program, the National Biotechnology Strategy, and an ambitious localization and investment agenda. We translate these national priorities into practical decisions for companies and investors — what to do, when, and why it matters to them.

Explore the Transformation
  • Vision 2030 and Health Sector Transformation
  • Localization and healthcare investment opportunities
  • National Biotechnology Strategy and digital health
Insights

Perspectives on a market in motion

Practical analysis on regulation, policy, market access, and investment in Saudi healthcare.

View All Insights

Let's discuss your Saudi healthcare strategy

Whether you are entering the market, registering a product, structuring an investment, or planning your next phase of growth, our advisors are ready to help you think it through.

Request a Consultation

Prefer email? Reach us directly at info@anwall.sa